Clinical trialNCT02289820CompletedPhase 1Interventional

A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults

SponsorMedImmune LLCEnrollment363Respiratory Syncytial Virus (RSV)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this study is to evaluate the safety, tolerability and immunogenicity of ascending doses of adjuvant in combination with a single dosage level of RSV sF in adults 60 years or older who are healthy or who have stable, chronic underlying medical conditions. This study will also provide preliminary safety and immunogenicity data to support concurrent dosing of MEDI7510 with influenza vaccine (IIV), and to assess the safety of MEDI7510 at a dose previously assessed in the Phase 1a study.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Craig Curtis, MD
Compass Research
Principal Investigator
clinicaltrials.gov ↗
Eric Sheldon, MD
Miami Research Associates
Principal Investigator
clinicaltrials.gov ↗
H. Keipp Talbot, MD
Vanderbilt University Medical Center
Principal Investigator
clinicaltrials.gov ↗
John Ervin, MD
The Center for Pharmaceutical Research
Principal Investigator
clinicaltrials.gov ↗
Judith Falloon, MD
MedImmune LLC
Study Director
clinicaltrials.gov ↗
Wayne Harper, MD
Wake Research Associates
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Orlando, Florida, United States
Research Site
South Miami, Florida, United States
Research Site
Kansas City, Missouri, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

IIVMEDI7510

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 Jan 2015
Primary completion: 24 Feb 2016
Completion: 24 Feb 2016
Last update posted: 15 Mar 2018
Registered enrollment: 363
Registry id: NCT02289820

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.